Cleveland Clinic Cancer Center highlights top 10 abstracts to watch for at ASTRO 2023.
New study findings help clinicians understand which patients with DCIS are most appropriate for radiation therapy.
Researchers are attempting to update and expand upon traditional tumor classification systems using recursive partitioning analysis, a modeling technique focused on predicting survival in patients with high-risk cutaneous squamous cell carcinoma.
Our radiation oncologists have compiled a list of abstracts recently presented at the annual meeting of the American Society for Radiation Oncology that they consider to be the most intriguing, clinically relevant and transformative.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
A study conducted in 22 adult patients with low-grade glioma found that concurrent temozolomide-based chemoradiation therapy does not adversely influence neurocognitive function during a 2-year treatment follow up.
A prospective pilot study conducted in 16 patients with brain metastases found that 18F fluciclovine PET CT demonstrated promising utility in distinguishing radiation necrosis from tumor progression among patients treated with stereotactic radiosurgery.
Adult patients with pathologic stage III or IV head and neck squamous cell carcinoma (HNSCC) are being sought for a prospective clinical study. Cleveland Clinic is one of 237 locations nationwide where the prospective, randomized, Phase III trial focused on adjuvant therapy is being conducted.
Researchers from Cleveland Clinic and OhioHealth have published results from a first-in-human trial evaluating feasibility of Temporally Feathered Radiation Therapy (TFRT), which is designed to reduce the toxicity of radiation treatment.
A group of researchers led by Jacob Scott, MD, DPhil, have validated a quantifiable, genomically guided parameter that serves as a predictor of the therapeutic benefit of RT for each individual patient.
A radiation oncologist and surgeon discuss how partial breast irradiation, novel tissue markers and deep inspiratory breath holds fit into Cleveland Clinic’s breast cancer radiation protocols.